New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.

Kary, S

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. [electronic resource] - Annals of the rheumatic diseases Mar 2006 - 405-7 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

0003-4967

10.1136/ard.2005.037424 doi


Adalimumab
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Etanercept
Female
Humans
Immunoglobulin G--adverse effects
Infliximab
Male
Middle Aged
Psoriasis--chemically induced
Receptors, Tumor Necrosis Factor
Tumor Necrosis Factor-alpha--antagonists & inhibitors